/Companies

FidoCure

YC W18

San Francisco, US · Founded 2018 · 14 employees · 23 known investors

Find your way into FidoCure

Sign up to see every warm intro you have to FidoCure

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the FidoCure team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

One Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development. The company leverages a dataset of 2 billion datapoints from dogs with naturally occurring cancer to serve as a comparative model for pharmaceutical R&D, helping drug developers validate efficacy and identify biomarkers before human trials.

Also known as OneHealthCompany, Inc. · FidoCure · The One Health Company · The One Health Company, FidoCure

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesOncologyUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (W18)

FidoCure was founded in 2018 by Christina Lopes and Benjamin Lewis.

CLChristina Lopes
Christina LopesCEO & FounderShe came to veterinary oncology from finance and international development, having worked in emerging markets at Lehman Brothers and Credit Suisse and served as a managing director at Cerberus Capital Management. She also consulted for the United Nations, lectured at Columbia University's Institute of Latin American Studies, and sat on the advisory board of the International Planned Parenthood Federation/Western Hemisphere Region; she is a Y Combinator alum and a World Economic Forum Young Global Leader.
BLBenjamin Lewis
Benjamin LewisCOOformer
CLchristina lopes
christina lopesCEO & Founder
PC
Pedro CarrascoChief of Staffformer
CM
Christi MillerHead of Operationsformer

Investors · 23

Andreessen Horowitzlisted by Andreessen HorowitzMenlo Park · $500K – $50M

How we know: a16z's portfolio · Y Combinator's founder network · Not right? Tell us

BioAdvancereportedConshohocken · $500K – $1.5M

How we know: Y Combinator's founder network · Not right? Tell us

Borealis VenturesreportedHanover · $1M – $2.5M

How we know: Y Combinator's founder network · Not right? Tell us

Lerer HippeaureportedNew York · $500K – $2M

How we know: Y Combinator's founder network · Not right? Tell us

Polaris PartnersreportedBoston · $500K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 10

MoichorMoichor is an animal diagnostics laboratory providing automated blood count and cytology testing for veterinarians across the United States. The company uses artificial intelligence and computer vision to deliver species-specific pathology results through both send-in laboratory services and an in-clinic hematology device.
VcahospitalsVCA Animal Hospitals operates a national network of veterinary hospitals providing primary care, specialty care, emergency care, urgent care, and boarding services for pets. The company combines advanced medical technology and procedures with compassionate care for pet owners and their animals.
Endpoint HealthEndpoint Health develops immunology-focused therapeutics paired with diagnostic tests designed to match individual patients with treatments suited to their biology for critical and chronic illnesses.
54Gene54Gene conducts genomics research and provides related services to increase the representation of African genetic data in medical research, which aims to advance healthcare solutions globally.
Petcure OncologyPetCure Oncology, founded in 2014, operates a network of veterinary cancer care centers offering stereotactic radiation therapy (SRS/SRT) and other cancer treatments for pets. It serves pet owners in the U.S. seeking advanced radiation oncology options for animals with cancer.
GamgeeGAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.
OmantaOmanta provides personalized scientific research support for complex disease cases, assigning PhD-level teams to build detailed molecular profiles from a patient's genomic, RNA, and protein data. It cross-references each patient's molecular profile against an internal reference cohort and biomedical literature to model therapeutic options and produce a research roadmap that informs the clinical team's decisions.</parameter> <parameter name="founders">[]
WagwalkingWag! is a marketplace that connects pet owners with local pet caregivers for services including dog walking, drop-in visits, pet sitting, and boarding. The platform vets caregivers through background checks and provides real-time updates and communication tools for pet owners to monitor their pets during service.
ImpriMedImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.
VetsterVetster operates an online marketplace and telehealth platform connecting pet owners with veterinary professionals for virtual appointments and pet care services. It serves pet parents across more than 100 countries.

Companies working in the same space as FidoCure.

Legal entities · 1

corporate structure
OneHealthCompany, Inc.

Frequently asked questions

What does FidoCure do?
One Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development. The company leverages a dataset of 2 billion datapoints from dogs with naturally occurring cancer to serve as a comparative model for pharmaceutical R&D, helping drug developers validate efficacy and identify biomarkers before human trials.
Who founded FidoCure?
FidoCure was founded by Christina Lopes, Benjamin Lewis in 2018.
Who are FidoCure's investors?
FidoCure's investors include Andreessen Horowitz, aVenture, Civilization Ventures Management, Llc, Gaingels, Global Brain, IKJ Capital, MaC Venture Capital, Mana Ventures and 15 more.
Where is FidoCure headquartered?
FidoCure is headquartered in San Francisco, US.